To study the influence of transcatheter hepatic arterial embolization on glucose metabolism , glucose tolerance tests were performed in hepatoma. Ten patients had hepatoma without chronic liver disease (control groupJ, twelve patients had h epatoma with chronic liver disease (CLD groupJ, and twenty-eight patients had diabetes mellitus with h epatoma (diabetic group) Glucose tolerance tests were done before and after e mbolization therapy using Lipiodol and/or Gelfoam The author evaluated changes of glucose tolerance after oral glucose loading, and the relationship between fasting blood glucose (FBG) and the liver function (SGPT value ) in three groups, before and after embolotherapy. In the control group , the glucose tolerance was not altered significantly. However, the glucose tolerance after embolotherapy was significantly impaired at 60, 90, and 120 minutes after glucose loading (P<0.05) in the CLD group.
The author evaluated changes of glucose tolerance after oral glucose loading, and the relationship between fasting blood glucose (FBG) and the liver function (SGPT value ) in three groups, before and after embolotherapy. In the control group , the glucose tolerance was not altered significantly. However, the glucose tolerance after embolotherapy was significantly impaired at 60, 90, and 120 minutes after glucose loading (P<0.05) in the CLD group.
In the diabetic group , there were impairrnent of glucose tolerance at 30.60.90. 120 and 180 minutes after glucose loa ding (P<O.OI). There was no significant relationship between the liver function (SGPT value) and FBG.
From the results . the author concluded that embolotherapy for hepatoma sometimes can cause significant impairment of glucose tolerance. especially in the patients with chronic liver disease and advanced diabetes m e llitus .
Therefore. careful management of diabetes before and after embolotherapy should be carried out for improvement of the patient's grognosis Index Words: Li ver neoplasms. therapeutic radiology 76 1.329 Chemotherapy . complications 952.458
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